✦ LIBER ✦

Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: Two-year angiographic and three-year clinical results from the SPIRIT II study

✍ Scribed by Yoshinobu Onuma; Shuzou Tanimoto; Peter Ruygrok; Jörg Neuzner; Jan J. Piek; Ashok Seth; Joachim J. Schofer; Gert Richardt; Marcus Wiemer; Didier Carrié; Leif Thuesen; Cecile Dorange; Karine Miquel-Hebert; Susan Veldhof; Patrick W. Serruys

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 145 KB
Volume: 76
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.22541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four-year clinical follow-up of the XIEN

Four-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT II trial

✍ Scot Garg; Patrick W. Serruys; Karine Miquel-Hebert; on behalf of the SPIRIT II 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 2 views

## Abstract This report describes the 4‐year clinical outcomes of the SPIRIT II study, which randomized 300 patients to treatment with the XIENCE V everolimus‐eluting stent (EES), or the TAXUS paclitaxel‐eluting stent. At 4‐year clinical follow‐up, which was available in 256 (85.3%) patients, treat

Five-year long-term clinical follow-up o

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial

✍ Marcus Wiemer; Patrick W. Serruys; Karine Miquel-Hebert; Franz-Josef Neumann; Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views